Nordic Life Science 1
PHOTO JENNY LEYMAN PHOTO STIG JARNES The COVID-19
pandemic has affected the Nordic life science industry in many ways, not least when it comes to the survival of small startups and certain jobs. This has resulted in the industry finding creative solutions and digital approaches are becoming more frequent. READ MORE ON PAGE 38 The days are busy for Sweden’s Mikael Dolsten. As head of Pfizer’s R&D he is at the scientific forefront of the fight against the COVID-19 pandemic. If everything goes well, the company could begin manufacturing its vaccine candidate by the end of the year. READ MORE ON PAGE 44 This year, 2020, is the year Recipharm celebrates 25 years of CDMO business. Chief Executive Officer and cofounder, Thomas Eldered looks back upon milestones, crucial turning points and the company’s goal of simplifying a product’s journey to market. READ MORE ON PAGE 52 Oslo Cancer Cluster (OCC) Innovation Park and Incubator plans to expand by 50 000 m2 in the coming years. The goal is to create an international innovation hub in cancer. Why? Because personalized medicine is changing cancer innovation. READ MORE ON PAGE 60